Share Price and Basic Stock Data
Last Updated: November 28, 2025, 7:46 am
| PEG Ratio | 1.88 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Bombay Super Hybrid Seeds Ltd operates within the agricultural products industry, showcasing a market capitalization of ₹1,118 Cr and a current share price of ₹107. The company reported a steady revenue increase, with sales rising from ₹191 Cr in FY 2022 to ₹228 Cr in FY 2023, and projected sales of ₹256 Cr for FY 2024. The trailing twelve months (TTM) sales stood at ₹354 Cr, indicating robust growth momentum. Quarterly sales also reflected variability, with a peak of ₹157 Cr in June 2024, suggesting strong seasonality in revenue generation. Notably, the company experienced a decline in sales to ₹28 Cr in September 2024, but quickly rebounded with ₹128 Cr in December 2024. The revenue growth trajectory demonstrates the company’s ability to adapt to market demands and capitalize on favorable agricultural conditions, which is crucial in the highly competitive agricultural sector.
Profitability and Efficiency Metrics
Bombay Super Hybrid Seeds Ltd reported a net profit of ₹28 Cr with a remarkable return on equity (ROE) of 28.8% and a return on capital employed (ROCE) of 21.2%. The company’s operating profit margin (OPM) stood at 10%, reflecting effective cost management despite fluctuations in sales. The quarterly operating profit peaked at ₹15 Cr in June 2025, while the net profit reached ₹12 Cr in the same quarter, demonstrating operational efficiency. The interest coverage ratio (ICR) of 5.78x indicates that the company generates sufficient earnings to cover its interest expenses, which is favorable compared to typical industry standards. However, the cash conversion cycle (CCC) of 335 days signals potential inefficiencies in managing working capital, particularly in inventory turnover and debtor collection, areas that warrant managerial focus to enhance profitability further.
Balance Sheet Strength and Financial Ratios
The balance sheet of Bombay Super Hybrid Seeds Ltd reflects a healthy financial position, with total assets amounting to ₹222 Cr and total liabilities at ₹222 Cr as of March 2025. The company reported reserves of ₹109 Cr and borrowings of ₹30 Cr, indicating a low leverage profile and a conservative approach to financing. The current ratio stood at 1.83, suggesting adequate short-term liquidity to cover immediate obligations. The price-to-book value (P/BV) ratio of 12.12x indicates that the market values the company significantly higher than its book value, which could reflect investor confidence in its growth prospects. Additionally, the enterprise value (EV) of ₹1,360.24 Cr highlights the company’s valuation in the context of its operational capacity. However, the high P/BV ratio may also indicate overvaluation, which could pose risks if growth does not meet market expectations.
Shareholding Pattern and Investor Confidence
Bombay Super Hybrid Seeds Ltd has a stable shareholding pattern, with promoters holding a significant 73.85% stake, reflecting strong control and commitment to the company’s long-term vision. The public holds 26.15% of the shares, with a steady increase in the number of shareholders from 8,915 in December 2022 to 16,915 in September 2025, indicating rising investor interest. Notably, foreign institutional investors (FIIs) have shown minimal involvement, holding 0.00% of shares, which may suggest a lack of international confidence or awareness in the company’s growth potential. This limited foreign investment could pose risks to liquidity and market perception. The dominance of promoters could also lead to potential governance issues if not balanced with public and institutional interests. Overall, the strong promoter backing combined with increasing public participation signals a positive outlook for investor confidence.
Outlook, Risks, and Final Insight
Looking ahead, Bombay Super Hybrid Seeds Ltd is positioned to benefit from expanding agricultural markets and increasing demand for hybrid seeds. However, the company faces risks associated with seasonal fluctuations in revenue, as evidenced by the variability in quarterly sales figures. The high cash conversion cycle indicates potential inefficiencies that could impact liquidity and operational performance. Furthermore, the absence of foreign institutional investment may limit the company’s visibility and attractiveness to broader investor bases. Should the company enhance its working capital management and attract diverse investors, it could unlock additional growth avenues. Conversely, failure to address these risks may hinder its growth trajectory. Overall, while Bombay Super Hybrid Seeds Ltd demonstrates strong fundamentals, strategic focus on operational efficiencies and investor relations will be crucial for sustained growth and market confidence.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Bombay Super Hybrid Seeds Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| GRM Overseas Ltd | 2,884 Cr. | 470 | 503/176 | 54.5 | 70.4 | 0.00 % | 12.1 % | 14.6 % | 2.00 |
| Freshtrop Fruits Ltd | 136 Cr. | 170 | 179/105 | 165 | 0.00 % | 6.12 % | 5.36 % | 10.0 | |
| City Crops Agro Ltd | 27.8 Cr. | 17.1 | 30.4/17.0 | 15.8 | 0.00 % | 8.46 % | 8.14 % | 10.0 | |
| Chamanlal Setia Exports Ltd | 1,286 Cr. | 259 | 447/242 | 13.6 | 153 | 0.97 % | 16.7 % | 14.2 % | 2.00 |
| Mangalam Global Enterprise Ltd | 503 Cr. | 15.3 | 18.5/11.2 | 19.2 | 6.86 | 0.07 % | 16.8 % | 14.6 % | 1.00 |
| Industry Average | 3,490.64 Cr | 269.22 | 26.99 | 110.30 | 0.33% | 11.71% | 12.10% | 4.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 102 | 21 | 69 | 36 | 117 | 34 | 76 | 30 | 157 | 28 | 128 | 46 | 153 |
| Expenses | 93 | 20 | 61 | 32 | 104 | 31 | 67 | 27 | 143 | 25 | 118 | 40 | 138 |
| Operating Profit | 9 | 1 | 8 | 3 | 13 | 3 | 9 | 4 | 14 | 3 | 10 | 6 | 15 |
| OPM % | 9% | 7% | 12% | 9% | 11% | 9% | 12% | 12% | 9% | 11% | 8% | 13% | 10% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 0 |
| Interest | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 2 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 8 | 1 | 7 | 2 | 11 | 2 | 8 | 3 | 12 | 2 | 9 | 5 | 13 |
| Tax % | 6% | 10% | 6% | 3% | 5% | 10% | 14% | -21% | 7% | 15% | 1% | 8% | 7% |
| Net Profit | 7 | 1 | 7 | 2 | 11 | 2 | 7 | 3 | 11 | 2 | 9 | 4 | 12 |
| EPS in Rs | 0.70 | 0.08 | 0.63 | 0.18 | 1.01 | 0.15 | 0.66 | 0.30 | 1.06 | 0.20 | 0.86 | 0.40 | 1.17 |
Last Updated: August 1, 2025, 11:05 pm
Below is a detailed analysis of the quarterly data for Bombay Super Hybrid Seeds Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 153.00 Cr.. The value appears strong and on an upward trend. It has increased from 46.00 Cr. (Mar 2025) to 153.00 Cr., marking an increase of 107.00 Cr..
- For Expenses, as of Jun 2025, the value is 138.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 40.00 Cr. (Mar 2025) to 138.00 Cr., marking an increase of 98.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from 6.00 Cr. (Mar 2025) to 15.00 Cr., marking an increase of 9.00 Cr..
- For OPM %, as of Jun 2025, the value is 10.00%. The value appears to be declining and may need further review. It has decreased from 13.00% (Mar 2025) to 10.00%, marking a decrease of 3.00%.
- For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 1.00 Cr..
- For Interest, as of Jun 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 5.00 Cr. (Mar 2025) to 13.00 Cr., marking an increase of 8.00 Cr..
- For Tax %, as of Jun 2025, the value is 7.00%. The value appears to be improving (decreasing) as expected. It has decreased from 8.00% (Mar 2025) to 7.00%, marking a decrease of 1.00%.
- For Net Profit, as of Jun 2025, the value is 12.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Mar 2025) to 12.00 Cr., marking an increase of 8.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 1.17. The value appears strong and on an upward trend. It has increased from 0.40 (Mar 2025) to 1.17, marking an increase of 0.77.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 5:37 am
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 31 | 63 | 110 | 82 | 75 | 103 | 171 | 191 | 228 | 256 | 358 | 354 |
| Expenses | 30 | 62 | 108 | 79 | 70 | 97 | 162 | 178 | 206 | 228 | 325 | 318 |
| Operating Profit | 1 | 1 | 1 | 3 | 4 | 6 | 9 | 14 | 22 | 28 | 33 | 36 |
| OPM % | 3% | 2% | 1% | 4% | 6% | 6% | 5% | 7% | 9% | 11% | 9% | 10% |
| Other Income | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 3 | 2 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 5 | 6 | 7 |
| Depreciation | 0 | 0 | 0 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 0 | 0 | 1 | 2 | 3 | 3 | 6 | 11 | 18 | 24 | 28 | 29 |
| Tax % | 62% | 37% | 34% | 35% | 26% | 23% | 5% | 5% | 6% | 6% | 6% | |
| Net Profit | 0 | 0 | 1 | 1 | 2 | 3 | 6 | 10 | 17 | 22 | 26 | 28 |
| EPS in Rs | 0.01 | 0.05 | 0.16 | 0.15 | 0.20 | 0.25 | 0.55 | 1.00 | 1.60 | 2.12 | 2.52 | 2.64 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 0.00% | 100.00% | 50.00% | 100.00% | 66.67% | 70.00% | 29.41% | 18.18% |
| Change in YoY Net Profit Growth (%) | 0.00% | 100.00% | -50.00% | 50.00% | -33.33% | 3.33% | -40.59% | -11.23% |
Bombay Super Hybrid Seeds Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2017-2018 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 28% |
| 3 Years: | 23% |
| TTM: | 20% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 91% |
| 5 Years: | 58% |
| 3 Years: | 36% |
| TTM: | 21% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 71% |
| 3 Years: | 37% |
| 1 Year: | -26% |
| Return on Equity | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 31% |
| 3 Years: | 32% |
| Last Year: | 29% |
Last Updated: September 5, 2025, 1:15 am
Balance Sheet
Last Updated: November 9, 2025, 1:47 pm
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 2 | 3 | 3 | 5 | 7 | 8 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 0 | 0 | 1 | 3 | 14 | 15 | 18 | 29 | 46 | 68 | 94 | 109 |
| Borrowings | 6 | 7 | 12 | 16 | 13 | 16 | 30 | 39 | 53 | 48 | 92 | 30 |
| Other Liabilities | 1 | 4 | 4 | 7 | 4 | 8 | 13 | 19 | 24 | 36 | 25 | 14 |
| Total Liabilities | 8 | 15 | 20 | 31 | 38 | 47 | 73 | 98 | 133 | 162 | 222 | 163 |
| Fixed Assets | 2 | 3 | 5 | 4 | 9 | 9 | 8 | 7 | 9 | 7 | 9 | 11 |
| CWIP | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Other Assets | 7 | 12 | 15 | 24 | 29 | 38 | 64 | 91 | 124 | 155 | 213 | 151 |
| Total Assets | 8 | 15 | 20 | 31 | 38 | 47 | 73 | 98 | 133 | 162 | 222 | 163 |
Below is a detailed analysis of the balance sheet data for Bombay Super Hybrid Seeds Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 10.00 Cr..
- For Reserves, as of Sep 2025, the value is 109.00 Cr.. The value appears strong and on an upward trend. It has increased from 94.00 Cr. (Mar 2025) to 109.00 Cr., marking an increase of 15.00 Cr..
- For Borrowings, as of Sep 2025, the value is 30.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 92.00 Cr. (Mar 2025) to 30.00 Cr., marking a decrease of 62.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 14.00 Cr.. The value appears to be improving (decreasing). It has decreased from 25.00 Cr. (Mar 2025) to 14.00 Cr., marking a decrease of 11.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 163.00 Cr.. The value appears to be improving (decreasing). It has decreased from 222.00 Cr. (Mar 2025) to 163.00 Cr., marking a decrease of 59.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from 9.00 Cr. (Mar 2025) to 11.00 Cr., marking an increase of 2.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 1.00 Cr., marking an increase of 1.00 Cr..
- For Other Assets, as of Sep 2025, the value is 151.00 Cr.. The value appears to be declining and may need further review. It has decreased from 213.00 Cr. (Mar 2025) to 151.00 Cr., marking a decrease of 62.00 Cr..
- For Total Assets, as of Sep 2025, the value is 163.00 Cr.. The value appears to be declining and may need further review. It has decreased from 222.00 Cr. (Mar 2025) to 163.00 Cr., marking a decrease of 59.00 Cr..
Notably, the Reserves (109.00 Cr.) exceed the Borrowings (30.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -5.00 | -6.00 | -11.00 | -13.00 | -9.00 | -10.00 | -21.00 | -25.00 | -31.00 | -20.00 | -59.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 17 | 15 | 12 | 19 | 15 | 25 | 16 | 31 | 14 | 14 | 7 |
| Inventory Days | 55 | 50 | 30 | 71 | 143 | 121 | 169 | 281 | 497 | 406 | 349 |
| Days Payable | 3 | 12 | 8 | 13 | 5 | 6 | 7 | 30 | 51 | 27 | 22 |
| Cash Conversion Cycle | 70 | 52 | 34 | 76 | 152 | 140 | 179 | 282 | 460 | 393 | 335 |
| Working Capital Days | 12 | 11 | 11 | 35 | 69 | 61 | 39 | 63 | 77 | 102 | 98 |
| ROCE % | 10% | 15% | 14% | 13% | 13% | 15% | 19% | 22% | 24% | 21% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 2.52 | 2.10 | 1.61 | 10.06 | 5.33 |
| Diluted EPS (Rs.) | 2.52 | 2.10 | 1.61 | 10.06 | 5.33 |
| Cash EPS (Rs.) | 2.64 | 2.25 | 1.73 | 11.26 | 7.12 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 9.98 | 7.46 | 5.37 | 37.63 | 27.57 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 9.98 | 7.46 | 5.37 | 37.63 | 27.57 |
| Revenue From Operations / Share (Rs.) | 34.19 | 24.48 | 21.72 | 184.68 | 163.28 |
| PBDIT / Share (Rs.) | 3.38 | 2.81 | 2.12 | 13.56 | 8.66 |
| PBIT / Share (Rs.) | 3.26 | 2.68 | 1.99 | 12.31 | 7.07 |
| PBT / Share (Rs.) | 2.67 | 2.24 | 1.70 | 10.51 | 5.82 |
| Net Profit / Share (Rs.) | 2.52 | 2.12 | 1.60 | 10.01 | 5.53 |
| PBDIT Margin (%) | 9.89 | 11.46 | 9.74 | 7.34 | 5.30 |
| PBIT Margin (%) | 9.53 | 10.93 | 9.15 | 6.66 | 4.32 |
| PBT Margin (%) | 7.82 | 9.15 | 7.82 | 5.68 | 3.56 |
| Net Profit Margin (%) | 7.36 | 8.64 | 7.36 | 5.41 | 3.38 |
| Return on Networth / Equity (%) | 25.22 | 28.38 | 29.78 | 26.59 | 20.04 |
| Return on Capital Employeed (%) | 32.34 | 35.32 | 35.58 | 31.46 | 23.00 |
| Return On Assets (%) | 11.90 | 13.69 | 12.62 | 10.75 | 7.97 |
| Long Term Debt / Equity (X) | 0.00 | 0.01 | 0.01 | 0.00 | 0.06 |
| Total Debt / Equity (X) | 0.88 | 0.61 | 0.93 | 0.99 | 1.05 |
| Asset Turnover Ratio (%) | 1.87 | 1.74 | 1.98 | 2.27 | 2.87 |
| Current Ratio (X) | 1.83 | 1.87 | 1.67 | 1.59 | 1.58 |
| Quick Ratio (X) | 0.15 | 0.16 | 0.13 | 0.36 | 0.39 |
| Inventory Turnover Ratio (X) | 2.14 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 5.78 | 6.44 | 7.34 | 7.51 | 6.95 |
| Interest Coverage Ratio (Post Tax) (X) | 5.30 | 5.86 | 6.54 | 6.55 | 5.44 |
| Enterprise Value (Cr.) | 1360.24 | 2381.64 | 3911.29 | 451.30 | 172.02 |
| EV / Net Operating Revenue (X) | 3.79 | 9.27 | 17.16 | 2.33 | 1.00 |
| EV / EBITDA (X) | 38.30 | 80.90 | 176.14 | 31.71 | 18.93 |
| MarketCap / Net Operating Revenue (X) | 3.54 | 9.09 | 16.93 | 2.13 | 0.85 |
| Price / BV (X) | 12.12 | 29.82 | 68.49 | 10.43 | 5.07 |
| Price / Net Operating Revenue (X) | 3.54 | 9.09 | 16.93 | 2.13 | 0.85 |
| EarningsYield | 0.02 | 0.01 | 0.00 | 0.02 | 0.03 |
After reviewing the key financial ratios for Bombay Super Hybrid Seeds Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 2.52. This value is below the healthy minimum of 5. It has increased from 2.10 (Mar 24) to 2.52, marking an increase of 0.42.
- For Diluted EPS (Rs.), as of Mar 25, the value is 2.52. This value is below the healthy minimum of 5. It has increased from 2.10 (Mar 24) to 2.52, marking an increase of 0.42.
- For Cash EPS (Rs.), as of Mar 25, the value is 2.64. This value is below the healthy minimum of 3. It has increased from 2.25 (Mar 24) to 2.64, marking an increase of 0.39.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 9.98. It has increased from 7.46 (Mar 24) to 9.98, marking an increase of 2.52.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 9.98. It has increased from 7.46 (Mar 24) to 9.98, marking an increase of 2.52.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 34.19. It has increased from 24.48 (Mar 24) to 34.19, marking an increase of 9.71.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 3.38. This value is within the healthy range. It has increased from 2.81 (Mar 24) to 3.38, marking an increase of 0.57.
- For PBIT / Share (Rs.), as of Mar 25, the value is 3.26. This value is within the healthy range. It has increased from 2.68 (Mar 24) to 3.26, marking an increase of 0.58.
- For PBT / Share (Rs.), as of Mar 25, the value is 2.67. This value is within the healthy range. It has increased from 2.24 (Mar 24) to 2.67, marking an increase of 0.43.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 2.52. This value is within the healthy range. It has increased from 2.12 (Mar 24) to 2.52, marking an increase of 0.40.
- For PBDIT Margin (%), as of Mar 25, the value is 9.89. This value is below the healthy minimum of 10. It has decreased from 11.46 (Mar 24) to 9.89, marking a decrease of 1.57.
- For PBIT Margin (%), as of Mar 25, the value is 9.53. This value is below the healthy minimum of 10. It has decreased from 10.93 (Mar 24) to 9.53, marking a decrease of 1.40.
- For PBT Margin (%), as of Mar 25, the value is 7.82. This value is below the healthy minimum of 10. It has decreased from 9.15 (Mar 24) to 7.82, marking a decrease of 1.33.
- For Net Profit Margin (%), as of Mar 25, the value is 7.36. This value is within the healthy range. It has decreased from 8.64 (Mar 24) to 7.36, marking a decrease of 1.28.
- For Return on Networth / Equity (%), as of Mar 25, the value is 25.22. This value is within the healthy range. It has decreased from 28.38 (Mar 24) to 25.22, marking a decrease of 3.16.
- For Return on Capital Employeed (%), as of Mar 25, the value is 32.34. This value is within the healthy range. It has decreased from 35.32 (Mar 24) to 32.34, marking a decrease of 2.98.
- For Return On Assets (%), as of Mar 25, the value is 11.90. This value is within the healthy range. It has decreased from 13.69 (Mar 24) to 11.90, marking a decrease of 1.79.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.88. This value is within the healthy range. It has increased from 0.61 (Mar 24) to 0.88, marking an increase of 0.27.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.87. It has increased from 1.74 (Mar 24) to 1.87, marking an increase of 0.13.
- For Current Ratio (X), as of Mar 25, the value is 1.83. This value is within the healthy range. It has decreased from 1.87 (Mar 24) to 1.83, marking a decrease of 0.04.
- For Quick Ratio (X), as of Mar 25, the value is 0.15. This value is below the healthy minimum of 1. It has decreased from 0.16 (Mar 24) to 0.15, marking a decrease of 0.01.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.14. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 24) to 2.14, marking an increase of 2.14.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 5.78. This value is within the healthy range. It has decreased from 6.44 (Mar 24) to 5.78, marking a decrease of 0.66.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 5.30. This value is within the healthy range. It has decreased from 5.86 (Mar 24) to 5.30, marking a decrease of 0.56.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,360.24. It has decreased from 2,381.64 (Mar 24) to 1,360.24, marking a decrease of 1,021.40.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.79. This value exceeds the healthy maximum of 3. It has decreased from 9.27 (Mar 24) to 3.79, marking a decrease of 5.48.
- For EV / EBITDA (X), as of Mar 25, the value is 38.30. This value exceeds the healthy maximum of 15. It has decreased from 80.90 (Mar 24) to 38.30, marking a decrease of 42.60.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.54. This value exceeds the healthy maximum of 3. It has decreased from 9.09 (Mar 24) to 3.54, marking a decrease of 5.55.
- For Price / BV (X), as of Mar 25, the value is 12.12. This value exceeds the healthy maximum of 3. It has decreased from 29.82 (Mar 24) to 12.12, marking a decrease of 17.70.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.54. This value exceeds the healthy maximum of 3. It has decreased from 9.09 (Mar 24) to 3.54, marking a decrease of 5.55.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Bombay Super Hybrid Seeds Ltd:
- Net Profit Margin: 7.36%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 32.34% (Industry Average ROCE: 11.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 25.22% (Industry Average ROE: 12.1%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 5.3
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.15
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 40.3 (Industry average Stock P/E: 26.99)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.88
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.36%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Agricultural Products | Shreenathji Industrial Estate, Plot No. 11, National Highway 8-B, Rajkot Dist. Gujarat 360023 | info@bombaysuper.in http://www.bombaysuperseeds.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Arvindkumar Kakadia | Chairman & Managing Director |
| Mr. Kiritkumar Kakadia | Executive Director & CFO |
| Mr. Hemang Baxi | Executive Director |
| Mr. Kishorkumar Kakadia | Executive Director |
| Mr. Jadavjibhai Kakadia | Executive Director |
| Mr. Dharmesh Chotai | Ind. Non-Executive Director |
| Mr. Amit Gadhiya | Ind. Non-Executive Director |
| Mr. Hardik Patel | Ind. Non-Executive Director |
| Mrs. Richa Kaushal Mashru | Ind. Non-Executive Director |
| Mr. Harshil Vasani | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Bombay Super Hybrid Seeds Ltd?
Bombay Super Hybrid Seeds Ltd's intrinsic value (as of 28 November 2025) is 107.97 which is 0.91% higher the current market price of 107.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 1,118 Cr. market cap, FY2025-2026 high/low of 180/106, reserves of ₹109 Cr, and liabilities of 163 Cr.
What is the Market Cap of Bombay Super Hybrid Seeds Ltd?
The Market Cap of Bombay Super Hybrid Seeds Ltd is 1,118 Cr..
What is the current Stock Price of Bombay Super Hybrid Seeds Ltd as on 28 November 2025?
The current stock price of Bombay Super Hybrid Seeds Ltd as on 28 November 2025 is 107.
What is the High / Low of Bombay Super Hybrid Seeds Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Bombay Super Hybrid Seeds Ltd stocks is 180/106.
What is the Stock P/E of Bombay Super Hybrid Seeds Ltd?
The Stock P/E of Bombay Super Hybrid Seeds Ltd is 40.3.
What is the Book Value of Bombay Super Hybrid Seeds Ltd?
The Book Value of Bombay Super Hybrid Seeds Ltd is 11.4.
What is the Dividend Yield of Bombay Super Hybrid Seeds Ltd?
The Dividend Yield of Bombay Super Hybrid Seeds Ltd is 0.00 %.
What is the ROCE of Bombay Super Hybrid Seeds Ltd?
The ROCE of Bombay Super Hybrid Seeds Ltd is 21.2 %.
What is the ROE of Bombay Super Hybrid Seeds Ltd?
The ROE of Bombay Super Hybrid Seeds Ltd is 28.8 %.
What is the Face Value of Bombay Super Hybrid Seeds Ltd?
The Face Value of Bombay Super Hybrid Seeds Ltd is 1.00.